Keyphrases
Antisense
100%
Peptide nucleic Acid
100%
9-Aminoacridine
100%
Murine Double Minute 2 (MDM2)
100%
Nucleic Acid Conjugates
100%
Cancer Cells
100%
Cell Viability
18%
JAR Cells
18%
Lipofectamine
18%
HeLa
9%
Anticancer Drugs
9%
Nucleic Acid Targets
9%
Further Development
9%
Fold Increase
9%
Antisense Peptide
9%
Oncogene
9%
MDM2 Protein
9%
Camptothecin
9%
Basis Mismatch
9%
P53 Level
9%
Initiation Site
9%
P53 Activity
9%
Transcriptional Activation
9%
Tumor Protein p53 (TP53)
9%
DNA Complex
9%
DNA Intercalation
9%
Gene Therapeutics
9%
MRNA Level
9%
Medicine and Dentistry
Cancer Cell
100%
Protein P53
100%
Antisense
100%
Aminoacridine
100%
Peptide Nucleic Acid
100%
Downregulation
100%
Mdm2
36%
Messenger RNA
27%
Oligomer
18%
Cell Viability
18%
Anticancer Drug
9%
Transactivation
9%
Camptothecin
9%
Nucleic Acid Targeting
9%
Base
9%
Oncogene
9%
Intercalating Agent
9%
Conjugate
9%
Transcription Initiation
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Downregulation
100%
Antisense
100%
Peptide Nucleic Acid
100%
P53
100%
Mdm2
36%
Messenger RNA
27%
Cell Viability
18%
Lipofectamine
18%
Conjugate
9%
Oncogene
9%
Anticancer
9%
Transcription Initiation
9%
Transactivation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
Malignant Neoplasm
100%
Peptide Nucleic Acid
100%
Aminoacridine
100%
Messenger RNA
27%
Lipofectamine
18%
Cell Viability
18%
Oligomer
18%
Nucleic Acid Targeting
9%
Protein MDM2
9%
Intercalating Agent
9%
Base
9%
Anticancer Drug
9%
Camptothecin
9%